402 related articles for article (PubMed ID: 19148592)
1. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients.
Karagöz B; Bilgi O; Gümüs M; Erikçi AA; Sayan O; Türken O; Kandemir EG; Oztürk A; Yaylaci M
Med Oncol; 2010 Mar; 27(1):29-33. PubMed ID: 19148592
[TBL] [Abstract][Full Text] [Related]
2. Changes of CD4+CD25+FOXP3+ and CD8+CD28- regulatory T cells in non-small cell lung cancer patients undergoing surgery.
Chen C; Chen D; Zhang Y; Chen Z; Zhu W; Zhang B; Wang Z; Le H
Int Immunopharmacol; 2014 Feb; 18(2):255-61. PubMed ID: 24345703
[TBL] [Abstract][Full Text] [Related]
3. Variation of blood T lymphocyte subgroups in patients with non- small cell lung cancer.
Wang WJ; Tao Z; Gu W; Sun LH
Asian Pac J Cancer Prev; 2013; 14(8):4671-3. PubMed ID: 24083723
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of peripheral CD8+CD28+ and CD8+CD28- T cells in advanced non-small cell lung cancer patients treated with chemo(radio)therapy.
Liu C; Jing W; An N; Li A; Yan W; Zhu H; Yu J
J Transl Med; 2019 Oct; 17(1):344. PubMed ID: 31623615
[TBL] [Abstract][Full Text] [Related]
5. The prognostic role of circulating CD8
An N; Wang H; Jia W; Jing W; Liu C; Zhu H; Yu J
J Transl Med; 2019 Dec; 17(1):402. PubMed ID: 31796037
[TBL] [Abstract][Full Text] [Related]
6. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
[TBL] [Abstract][Full Text] [Related]
7. Increased CD8+CD28+ T cells independently predict better early response to stereotactic ablative radiotherapy in patients with lung metastases from non-small cell lung cancer.
Liu C; Hu Q; Hu K; Su H; Shi F; Kong L; Zhu H; Yu J
J Transl Med; 2019 Apr; 17(1):120. PubMed ID: 30971280
[TBL] [Abstract][Full Text] [Related]
8. Elevated Circulating CD4
Hu X; Gu Y; Zhao S; Hua S; Jiang Y
Cancer Biother Radiopharm; 2019 Jun; 34(5):325-333. PubMed ID: 30925076
[No Abstract] [Full Text] [Related]
9. Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapy.
Liu C; Wu S; Meng X; Liu G; Chen D; Cong Y; Shen G; Sun B; Wang W; Wang Q; Gao H; Liu X
Oncotarget; 2017 Jun; 8(26):43427-43438. PubMed ID: 28624781
[TBL] [Abstract][Full Text] [Related]
10. Aberrant Alteration of Circulating Lymphocyte Subsets in Small Cell Lung Cancer Patients Treated with Radiotherapy.
Li H; Yu H; Lan S; Zhao D; Liu Y; Cheng Y
Technol Cancer Res Treat; 2021; 20():15330338211039948. PubMed ID: 34851203
[No Abstract] [Full Text] [Related]
11. Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma.
Meloni F; Morosini M; Solari N; Passadore I; Nascimbene C; Novo M; Ferrari M; Cosentino M; Marino F; Pozzi E; Fietta AM
Hum Immunol; 2006; 67(1-2):1-12. PubMed ID: 16698419
[TBL] [Abstract][Full Text] [Related]
12. Suppressive effects of gemcitabine plus cisplatin chemotherapy on regulatory T cells in nonsmall-cell lung cancer.
Chen C; Chen Z; Chen D; Zhang B; Wang Z; Le H
J Int Med Res; 2015 Apr; 43(2):180-7. PubMed ID: 25659373
[TBL] [Abstract][Full Text] [Related]
13. [Distribution and Clinical Significance of CTLA-4, PD-1 and PD-L1 in Peripheral Blood of Patients with Small Cell Lung Cancer].
Li H; Liu Y; Liu Y; Liu J; Zhao D; Wang Y; Cheng Y
Zhongguo Fei Ai Za Zhi; 2017 Nov; 20(11):755-760. PubMed ID: 29167005
[TBL] [Abstract][Full Text] [Related]
14. [The change of periphery and centra CD4(+);CD25(+);Treg, CD8(+);CD28(-);Treg in the MOG induced model of experimental autoimmune encephalomyelitis].
Shang XF; Xi NN; Wang T; Lv J; Han Z; Zheng RY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Aug; 26(8):746-9. PubMed ID: 20619099
[TBL] [Abstract][Full Text] [Related]
15. Discrepant Clinical Significance of CD28
Shen XH; Xu P; Yu X; Song HF; Chen H; Zhang XG; Wu MY; Wang XF
Viral Immunol; 2018 Oct; 31(8):548-558. PubMed ID: 30117787
[TBL] [Abstract][Full Text] [Related]
16. Local CD4+, CD8+ and CD56+ reactions to lung cancer in regard to pathohistological type and clinical stage.
Jusufovic E; Iljazovic E; Kosnik M; Keser D; Korosec P; Zukic E; Prnjavorac B; Sejdinović R; Ajanović E
Med Glas (Zenica); 2011 Feb; 8(1):101-8. PubMed ID: 21263406
[TBL] [Abstract][Full Text] [Related]
17. Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC).
Erfani N; Mehrabadi SM; Ghayumi MA; Haghshenas MR; Mojtahedi Z; Ghaderi A; Amani D
Lung Cancer; 2012 Aug; 77(2):306-11. PubMed ID: 22608141
[TBL] [Abstract][Full Text] [Related]
18. [Changes of CD4+ CD25+ and CD8+ CD28- T regulatory cells in spontaneous tolerance of inbred rat orthotopic liver transplantation].
You P; Liu YL; Chen GD
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):266-70. PubMed ID: 16778969
[TBL] [Abstract][Full Text] [Related]
19. Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression.
Wang Y; Zhou N; Zhu R; Li X; Sun Z; Gao Y; Liu W; Meng C; Ge Y; Bai C; Li T; Liu H
BMC Pulm Med; 2021 Sep; 21(1):282. PubMed ID: 34488711
[TBL] [Abstract][Full Text] [Related]
20. CD8
Huang B; Liu R; Wang P; Yuan Z; Yang J; Xiong H; Zhang N; Huang Q; Fu X; Sun W; Li L
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32606053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]